Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients With Systemic Lupus Erythematosus-Reference-Cited by-同舟云学术

Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients With Systemic Lupus Erythematosus

Published:2020-10-28 Issue:12 Volume:72 Page:1971-1980
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Fernandez‐Ruiz Ruth¹^ORCID,Masson Mala¹,Kim Mimi Y.²,Myers Benjamin³,Haberman Rebecca H.¹^ORCID,Castillo Rochelle¹,Scher Jose U.¹,Guttmann Allison¹,Carlucci Philip M.¹,Deonaraine Kristina K.¹,Golpanian Michael¹,Robins Kimberly¹,Chang Miao¹,Belmont H. Michael¹,Buyon Jill P.¹^ORCID,Blazer Ashira D.¹,Saxena Amit¹,Izmirly Peter M.¹,

Affiliation:

1. New York University School of Medicine New York New York

2. Albert Einstein College of Medicine New York New York

3. Cornell University Ithaca New York

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Bloomberg Philanthropies

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41450

Reference51 articles.

1. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020

2. Kidney disease is associated with in-hospital death of patients with COVID-19

3. HealthNYC.Age adjusted rate of fatal lab confirmed COVID‐19 cases per 100 000 by race/ethnicity group. April 2020. URL:https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-deaths-race-ethnicity-04082020-1.pdf.

4. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

5. Exuberant elevation of IP‐10, MCP‐3 and IL‐1ra during SARS‐CoV‐2 infection is associated with disease severity and fatal outcome;Yang Y;medRxiv,2020

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lupus and infections;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus;Lupus;2024-02-09

3. Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis;Lupus;2024-01-09

4. Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection;Rheumatology and Therapy;2024-01-04

5. CT scan and clinical characteristics in COVID-19 patients with and without systemic lupus erythematosus;Chirurgia;2023-12